ISSN (print) 1726-9806     ISSN (online) 1818-474X
No. 3 (2021), INTENSIVE CARE IN CARDIOSURGERY
No. 3 (2021)
INTENSIVE CARE IN CARDIOSURGERY

Delivery of Gaseous Nitric Oxide to the Extracorporeal Circulation Circuit: Experimental and Clinical Data: a review

Published 26.10.2021
Vladimir V. Pichugin
Privolzhsky Research Medical University, Nizhniy Novgorod, Russia; Specialized Cardiac Surgical Clinical Hospital, Nizhniy Novgorod, Russia
https://orcid.org/0000-0001-7724-0123
A.E. Bautin
Almazov National Medical Research Centre, St. Petersburg, Russia
https://orcid.org/0000-0001-5031-7637
S.E. Domnin
Specialized Cardiac Surgical Clinical Hospital, Nizhniy Novgorod, Russia
https://orcid.org/0000-0002-7146-5927
M.V. Ryazanov
Privolzhsky Research Medical University, Nizhniy Novgorod, Russia; Specialized Cardiac Surgical Clinical Hospital, Nizhniy Novgorod, Russia
https://orcid.org/0000-0002-5195-3608
E.V. Sandalkin
Privolzhsky Research Medical University, Nizhniy Novgorod, Russia; Specialized Cardiac Surgical Clinical Hospital, Nizhniy Novgorod, Russia
https://orcid.org/0000-0002-4198-6772
#2021-3
PDF_2021-3_108-116 (Russian)
HTML_2021-3_108-116 (Russian)

Keywords

nitric oxide
artificial circulation
pulmonary hypertension
pulmonaruy artery pressure
Cardiopulmonary Bypass
Extracorporeal Circulation

How to Cite

Pichugin V.V., Bautin A.E., Domnin S.E., Ryazanov M.V., Sandalkin E.V. Delivery of Gaseous Nitric Oxide to the Extracorporeal Circulation Circuit: Experimental and Clinical Data: a review. Annals of Critical Care. 2021;(3):108–116. doi:10.21320/1818-474X-2021-3-108-116.
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA ГОСТ

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Statistics

Annotation views: 378
PDF_2021-3_108-116 (Russian) downloads: 172
HTML_2021-3_108-116 (Russian) downloads: 113

Language

English Русский

Most reader

Social Networks

Keywords

Abstract

Introduction. Usually, gaseous nitric oxide (NO) is supplied to the patient by inhalation, adding to the inhaled gas mixture during spontaneous breathing, or supplying it to the inspiratory part of the ventilator. It is believed that the main point of its action is the pulmonary vasculature, where it exhibits an expanding effect, thus improving the oxygenation of arterial blood and reducing the pulmonary artery pressure. However, data from recent experimental clinical studies suggest that the addition of NO directly to the gas mixture supplied to the oxygenator makes it possible to systemically deliver NO into the bloodstream and, thereby, reduce the inflammatory response of the whole body caused by the extracorporeal circuit (cardiopulmonary bypass [CPB] or extracorporeal membrane oxygenation [ECMO]). Materials and methods. The search for publications was carried out in electronic databases PubMed, EMBASE. The last search term was December 30, 2020. The search term included the following words: “nitric oxide” and “artificial circulation” or “ECMO”. Only experimental and clinical randomized controlled blinded studies were selected for inclusion in the review. Results. The article analyzes data from recent studies related to the delivery of gaseous NO to the extracorporeal circuit, among which the issues of both NO delivery into the cardiopulmonary bypass line and the systemic and organ effects of nitric oxide delivered to the circuit are considered. The cardioprotective and anti-inflammatory effects of NO supplied to the extracorporeal circulation are considered in detail, as well as its effect on the lungs and kidneys. Conclusions. Further new randomized trials are needed to determine the place of the technology for supplying gaseous nitric oxide to the line of heart-lung machines or ECMO in modern cardiac surgery.

PDF_2021-3_108-116 (Russian)
HTML_2021-3_108-116 (Russian)

References

  1. Пичугин В.В., Сейфетдинов И.Р., Медведев А.П., Домнин С.Е. Ингаляционный оксид азота в профилактике ишемических и реперфузионных повреждений сердца при операциях с искусственным кровообращением. Медицинский альманах. 2019; 1: 81–7. DOI: 10.21145/2499-9954-2019-1-81-87 [Pichugin V.V., Seyfetdinov I.R., Medvedev A.P., Domnin S.E. Inhaled nitric oxide in the prevention of ischemic and reperfusion injuries of the heart during operations with artificial circulation. Medical almanach, 2019; 1: 81–7. DOI: 10.21145/2499-9954-2019-1-81-87 (In Russ)]
  2. Gianetti J., Del Sarto P., Bevilacqua S., et al. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg. 2004; 127: 44–50. DOI: 10.1016/j.jtcvs.2002.08.001
  3. Checchia P.A., Bronicki R.A., Muenzer J.T., et al. Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children — a randomized trial. J Thorac Cardiovasc Surg. 2013; 146: 530–6. DOI: 10.1016/j.jtcvs.2012.09.100
  4. James Ch., Millar J.C., Horton S., et al. Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive Care Med. 2016; 42(11): 1744–52. DOI: 10.1007/s00134-016-4420-6
  5. Kamenshchikov N.O., Mandel I.A., Podoksenov Yu.K., et al. Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: randomized trial. J Thorac Cardiovasc Surg. 2019; 157(6): 2328–36. e12018. DOI: 10.1016/j.jtcvs.2018.08.117
  6. Hataishi R., Rodrigues A.C., Neilan T.G., et al. Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2006; 291: H379–H384. DOI: 10.1152/ajpheart.01172.2005
  7. Chello M., Mastroroberto P., Perticone F., et al. Nitric oxide modulation of neutrophil-endothelium interaction: difference between arterial and venous coronary bypass grafts. J Am Coll Cardiol. 1998; 31: 823–6.
  8. Schlapbach L.J., Horton S.B., Long D.A., et al. Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial. BMJ Open. 2019; 9: e026664. DOI: 10.1136/bmjopen-2018-026664
  9. Kebir D.E., Hubert B., Taha R., et al. Effects of inhaled nitric oxide on inflammation and apoptosis after cardiopulmonary bypass. Chest. 2005; 128(4): 2910–17. DOI: 10.1378/chest.128.4.2910
  10. Toomasian J.M., Jeakle M.M.P., Langley M.W., et al. Nitric Oxide Attenuates the Inflammatory Effects of Air During Extracorporeal Circulation. ASAIO J. 2020; 66(7): 818–24. DOI: 10.1097/MAT.0000000000001057
  11. Rossidis A.C., Lawrence K.M., Mejaddam A.Y,. et al. The Effects of Nitric Oxide in Oxygenator Sweep Gas During Extracorporeal Circulation in a Neonatal Ovine Model. ASAIO J. 2020; 66(6): 671–6. DOI: 10.1097/MAT.0000000000001047
  12. Каменщиков Н.О., Подоксенов Ю.К., Подоксенов А.Ю., Кравец Т.В. Патент РФ RU 2 628 643 C1 «Способ защиты легких от ишемического и реперфузионного повреждения во время кардиохирургических вмешательств с искусственным кровообращением». [Kamenshchikov N.O., Podoksenov Yu.K., Podoksenov A.Yu., Kravets T.V. RF Patent RU 2628643 C1 “Method of protecting the lungs from ischemic and reperfusion injury during cardiac surgery with artificial circulation” (In Russ)]
  13. Vermeulen WindsantC., de Wit N.C.J., Sertorio J.T.C., et al. Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage. Front Physiol. 2014; 5: 340. DOI: 10.3389/fphys.2014.00340. eCollection 2014
  14. Legrand M., Mik E.G., Johannes T., et al. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med. 2008; 14(7–8): 502–16. DOI: 10.2119/2008-00006.Legrand
  15. Khorashadi M., Bokoch M.P., LegrandM. Is nitric oxide the forgotten nephroprotective treatment during cardiac surgery? Ann. Intensive Care. 2020; 10: 22. DOI: 10.1186/s13613-020-0631-7
  16. Lei C., Berra L., Rezoagli E., et al. Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Am J Respir Crit Care Med. 2018; 198: 1279–87. DOI: 10.1164/rccm.201710–2150OC
  17. Ruan S.Y., Huang T.M., Wu H.Y., et al. Inhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and metaanalysis of randomized trials. Crit Care. 2015; 19: 137. DOI: 10.1186/s13054-015-0880-2
  18. Gebistorf F., Karam O., Wetterslev J., Afshari A. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016. DOI: 10.1002/14651 858.CD002 787.pub3
  19. Hu J., Spina S., Zadek F., et al. Effect of nitric oxide on postoperative acute kidney injury in patients who underwent cardiopulmonary bypass: a systematic review and metaanalysis with trial sequential analysis. Mais Ann Intensive Care. 2019; 9: 129. DOI: 10.1186/s13613-019-0605-9
  20. Goździk W., Albert J., Harbut P., et al. Prolonged exposure to inhaled nitric oxide transiently modifies tubular function in healthy piglets and promotes tubular apoptosis. Acta Physiol. 2009; 195: 495–502. Epub 2008 Nov 12. DOI: 10.1111/j.1748-1716.2008.01908.x
  21. Legrand M., Mebazaa A., Ronco C., Januzzi J.L. When cardiac failure, kidney dysfunction, and kidney injury intersect in acute conditions: the case of cardiorenal syndrome. Crit Care Med. 2014; 42: 2109–17. DOI: 10.1097/CCM.0000000000000404
  22. Coutrot M., Depret F., Legrand M. Is nitric oxide nephro- or cardioprotective? Am J Respir Crit Care Med. 2019; 199: 1441–2. DOI: 10.1164/rccm.201812-2344LE
  23. Kamenshchikov N.O., Anfinogenova Y.J., Kozlov B.N., et al. Nitric oxide delivery during cardiopulmonary bypass reduces acute kidney injury: A randomized trial. Thorac Cardiovasc Surg. 2020 Jun 25: S0022-5223(20)31541-5. DOI: 10.1016/j.jtcvs.2020.03.182
  24. Bennett M., Thuys C., Augustin S., et al. The Safe Addition of Nitric Oxide into the Sweep Gas of the Extracorporeal Circuit during Cardiopulmonary Bypass and Extracorporeal Life Support. J Extra Corpor Technol. 2018; 50: 260–4. PMID: 30581236. PMCID: PMC6296446.
  25. James C., Millar J., Horton S.B., et al. Nitric oxide administration during pediatric cardiopulmonary bypass: A randomised controlled trial. Intensive Care Med. 2016; 42:1744–52. DOI: 10.1007/s00134-016-4420-6
  26. Raut M.S., Maheshwari A. Inhaled nitric oxide, methemoglobinemia, and route of delivery. Saudi J Anaesth. 2017; 11: 364. DOI: 10.4103/sja.SJA_82_17
  27. Wright R.O., Lewander W.J., Woolf A.D. Methemoglobinemia: Etiology, pharmacology, and clinical management. Ann Emerg Med. 1999; 34: 646–56. DOI: 10.1016/s0196-0644(99)70167-8
  28. INOmax DSIR Plus operational manual. Mallinckrodt Pharmaceuticals. Rev-03, 2015–07.
  29. Chiletti R., Horton S., Bednarz A., et al. Safety of nitric oxide added to the ECMO circuit: A pilot study in children. Perfusion. 2018; 33: 74–6. DOI: 10.1177/0267659117720495
  30. Каменщиков Н.О. Защита миокарда от ишемически-реперфузионного повреждения путем доставки оксида азота в контур экстракорпоральной циркуляции при операциях аортокоронарного шунтирования [диссертация]. Томск, 2019. [Kamenshikov N.O. Protection of the myocardium from ischemia-reperfusion injury by delivering nitric oxide into the extracorporeal circulation during coronary artery bypass grafting [dissertation]. Tomsk, 2019. 147 p. (In Russ)]
  31. БурановС.Н., Карелин В.И., Пименов О.А. и др. Плазмохимическая установка для NO-терапии. Медиаль, 2013; 4(9): 46. [Buranov S.N., Karelin V.I., Pimenov O.A., et al. Plasma-chemical installation for NO-therapy. Medial, 2013; 4(9): 46. (In Russ)]
  32. БурановС.Н., Буянов А.Б., Воеводин С.В. и др. Аппарат для ингаляционной NO-терапии. Биорадикалы и Антиоксиданты. 2016; 3(3): [Buranov S.N., Buyanov A.B., Voevodin S.V., et al. Apparatus for inhalation NO-therapy. Bioradicals and Antioxidants. 2016; 3(3): 225. (In Russ)]
  33. БурановС.Н., Карелин В.И., Селемир В.Д. и др. Аппарат ингаляционной терапии оксидом азота «Тианокс» и первый опыт его клинического применения в кардиохирургии. В материалах научно-образовательной конференции: «Актуальные вопросы и инновационные технологии в анестезиологии и реаниматологии». 2018 г., 30–31 марта; Санкт-Петербург: с. 4–9. [Buranov S.N., Karelin V.I., Selemir V.D., et al. The device for inhalation therapy with nitric oxide “Tianox” and the first experience of its clinical use in cardiac surgery. Materials of scientific and educational conf. “Actual issues and innovative technologies in anesthesiology and resuscitation”. 2018 March 30–31. St. Petersburg. P. 4–9. (In Russ)]
  34. БаутинА.Е., Селемир В.Д., Шафикова А.И. и др. Оценка клинической эффективности и безопасности терапии оксидом азота, синтезированным из атмосферного воздуха, в послеоперационном периоде кардиохирургических вмешательств. Трансляционная медицина. 2021; 8(1): 38–50. DOI: 18705/2311-4495-2020-8-1-38-50 [Bautin A.E., Selemir V.D., Shafikova A.I., et al. Evaluation of the clinical efficacy and safety of nitric oxide synthesized from room air in the postoperative period of cardiac surgery. Translational medicine. 2021; 8(1): 38–50. DOI: 10.18705/2311-4495-2020-8-1-38-50 (In Russ)]
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2021 ANNALS OF CRITICAL CARE

Most read articles by the same author(s)